Cart 0 Product Products (empty)

No products

To be determined Shipping
0,00 € Total

Check out

Product successfully added to your shopping cart


There are 0 items in your cart. There is 1 item in your cart.

Total products (tax incl.)
Total shipping (tax incl.) To be determined
Total (tax incl.)
Continue shopping Proceed to checkout

Clinical evaluation of the effectiveness and the skin tolerance of SilveRpès
versus a placebo on patients with labial herpes

Study conducted by Groupe Dermscan, a center of clinical experimentation chartered by the French Ministry of Health and by AFSSAPS (French Health Products Safety Agency), ISO 9001/2008 certified.

Objectives of the trial

  • Evaluation of the clinical effectiveness based on the specific parameters of a cold sore: dryness, erythema, edema, vesicles, re-epithelialization, lesion size, scabs and exudates;
  • Clinical evaluation of the tolerance to the products under study;
  • Subjective evaluation of their sensory characteristics, their effectiveness, their tolerance to a later application;

Conclusions about the effectiveness and the tolerance of SilveRpès

  • SilveRpès  results in a faster dissolution of herpes symptoms rather than produced by the placebo on the following parameters: cyst,  re-epithelialization, size and scab;
  • SilveRpès  demonstrated a good tolerance on the skin, the placebo having demonstrated a very good tolerance on the skin;
  • SilveRpès was appreciated by the volunteers for its organoleptic characteristics and its effectiveness; most volunteers wish to continue the use of SilveRpès  and would be likely to buy it at the end of the test.


  • Double-blind study versus a placebo;
  • Kinetic: D0-D1-D2-D3-D4-D5-D6-D7-D8-D9 & D10;
  • Zone: labial zone presenting the cold sore and/or the symptoms.

Related documents

  1. Clinical results of SilveRpès on cysts
  2. Clinical results of SilveRpès on re-epithelialization
  3. Clinical results of SilveRpès  on the size of the lesion
  4. Clinical results of SilveRpès on the scabs